Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave.

Vaccines (Basel) · 2023 · PMC10302227 · PMID 37376510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Prior to SARS-CoV-2 infection, these PD patients had a lower antibody level compared with SARS-CoV-2 naive patients, but this difference did not reach statistical significance, probably due to the small number of patients in our cohort.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.